Showing results (2091-2100 of 2,140) with videos related to

Sort By:
Pageof 214
Clinical and Translational Medicine|September 23, 2023
Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsJiaojiao Yang, Liyue Sun, Xiao-Yun Liu, et al.
Oral Oncology|April 18, 2025
Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinomaRevadhi C Chelvarajah, Ye Liu, Jie Su, et al.
Molecular Oncology|April 27, 2020
RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumorsXi Yuan, Zhiyu Tang, Rong Du, et al.
BMC Neurology|July 26, 2018
Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodologyYiqi Lin, Binyin Li, Huidong Tang, et al.
Archives of Toxicology|September 6, 2017
Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicityLili Cheng, Mengmeng Ge, Zhou Lan, et al.
British Journal of Cancer|June 6, 2018
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathwayJian-Ye Liu, Qing-Hai Zeng, Pei-Guo Cao, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|November 19, 2009
[Analysis of clinical characteristics of gastrointestinal cancer in Heilongjiang province, China 1998 to 2007]Xiao-ming Zou, Xi-shan Wang, Yun-long Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced GlioblastomaErik Ladomersky, Lijie Zhai, Alicia Lenzen, et al.
Cell Death and Differentiation|February 15, 2019
mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesisChunjia Li, Hongyu Chen, Zhou Lan, et al.
Thoracic Cancer|August 19, 2023
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic featuresNong Yang, Hai-Lin Yue, Bai-Hua Zhang, et al.
Pageof 214